ESMO 2024 Congress

Metabolon is proud to announce its participation at the upcoming ESMO 2024 Congress in Barcelona, Spain.

As a leading provider of metabolomics solutions, Metabolon recognizes the importance of engaging with the global oncology community to advance research and innovation in cancer treatment and diagnosis. The ESMO Congress serves as a premier platform for scientific exchange, bringing together oncology professionals from around the world to discuss the latest developments in oncology research and clinical practice. Metabolon looks forward to showcasing its cutting-edge metabolomics technologies and research insights, demonstrating our commitment to supporting advancements in personalized medicine and precision oncology.

Metabolomics plays a pivotal role in advancing oncology research by providing comprehensive insights into the metabolic alterations associated with cancer development, progression, and response to treatment. Integrating metabolomics in to oncology research provides insight not only into the cellular and microenvironment metabolism, but also informs feedback loops, epigenetic influences, treatment and efficacy solutions and biomarker discovery.

For more event information, you can read visit the official event website or read the official program.

Join us at Booth 654

Don’t miss the opportunity to connect with Metabolon at ESMO 2024 Congress in Barcelona, Spain. Stop by booth 654 to meet our team, explore our metabolomics solutions, and discover how we can propel your research forward. Schedule a meeting here to guarantee 1:1 time with a metabolomics expert.

Event Location

Av. Joan Carles I, 64
08908 L’hospitalet de Llobregat
Barcelona, Spain
Google Maps